These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18711233)

  • 1. Evaluation of pilot methadone maintenance therapy in Georgia (Caucasus).
    Gambashidze N; Sikharulidze Z; Piralishvili G; Gvakharia N
    Georgian Med News; 2008; (160-161):25-30. PubMed ID: 18711233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of methadone on drug use and risky sex in China.
    Qian HZ; Hao C; Ruan Y; Cassell HM; Chen K; Qin G; Yin L; Schumacher JE; Liang S; Shao Y
    J Subst Abuse Treat; 2008 Jun; 34(4):391-7. PubMed ID: 17869049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
    Longshore D; Annon J; Anglin MD; Rawson RA
    Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.
    Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM
    Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary evaluation of methadone program in Kraków].
    Kamenczak A; Chrostek Maj J; Kroch S; Groszek B
    Przegl Lek; 2000; 57(10):525-30. PubMed ID: 11199879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Needs assessment and treatment compliance at state opioid substitution treatment programes in Georgia.
    Piralishvili G; Gamkrelidze I; Nikolaishvili N; Chavchanidze M
    Georgian Med News; 2013 Jan; (214):28-32. PubMed ID: 23388531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance.
    Calsyn DA; Malcy JA; Saxon AJ
    J Subst Abuse Treat; 2006 Mar; 30(2):159-63. PubMed ID: 16490679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence.
    Darke S; Hetherington K; Ross J; Lynskey M; Teesson M
    Drug Alcohol Rev; 2004 Jun; 23(2):177-83. PubMed ID: 15370024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of state opioid substitution treatment program in Georgia.
    Piralishvili G; Chavchanidze M; Gamkrelidze I; Nikolaishvili N
    Georgian Med News; 2014 Apr; (229):62-6. PubMed ID: 24850608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychotropic drugs in opioid addicts on methadone treatment].
    Ferris GN
    Dis Nerv Syst; 1976 Jul; 37(7):400-3. PubMed ID: 954561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of retention in methadone programs: a signal detection analysis.
    Villafranca SW; McKellar JD; Trafton JA; Humphreys K
    Drug Alcohol Depend; 2006 Jul; 83(3):218-24. PubMed ID: 16384657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of needle/syringe exchange program in Tbilisi.
    Otiashvili D; Gambashidze N; Kapanadze E; Lomidze G; Usharidze D
    Georgian Med News; 2006 Nov; (140):62-5. PubMed ID: 17179591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of oral methadone dose in methadone injecting patients: a pilot study.
    Eap CB; Felder C; Golay KP; Uehlinger C
    J Addict Dis; 2003; 22(3):7-17. PubMed ID: 14621341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.